YZi Labs has criticized CEA Industries for adopting a "poison pill" strategy and amending its bylaws, actions perceived as attempts to hinder shareholder rights. YZi Labs claims these measures are designed to entrench the current board's position, noting the postponement of CEA's 2025 annual meeting beyond December 17th. Additionally, YZi Labs disputes CEA's assertion of not considering alternative token strategies, highlighting CEO David Namdar's November 2025 remarks about exploring assets like Solana. YZi Labs calls for a fair director nomination and election process, urging the board to cease obstructive actions.